Predictors of All-Cause Mortality and Liver-Related Mortality in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)-Reference-Cited by-同舟云学术

Predictors of All-Cause Mortality and Liver-Related Mortality in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)

Published:2013-06-18 Issue:10 Volume:58 Page:3017-3023
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Stepanova Maria,Rafiq Nila,Makhlouf Hala,Agrawal Ritambhara,Kaur Ishmeet,Younoszai Zahra,McCullough Arthur,Goodman Zachary,Younossi Zobair M.

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10620-013-2743-5.pdf

Reference38 articles.

1. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980;55:434–438.

2. Fracanzani AL, Valenti L, Bugianesi E, et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology. 2008;48:792–798.

3. Ong JP, Younossi ZM. Epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Clin Liver Dis. 2007;11:1–16.

4. Rafiq N, Younossi ZM. Effects of weight loss on non-alcoholic fatty liver disease. Semin Liver Dis. 2008;28:427–433.

5. Younossi Z, Stepanova M, Afendy M, et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988–2008. Clin Gastroenterol Hepatol. 2011;9:524–530.

Cited by 245 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A landscape of liver cirrhosis and transplantation in Mexico: changing leading causes and transplant as response;Annals of Hepatology;2024-09

2. Association between longitudinal biomarkers and major adverse liver outcomes in patients with non-cirrhotic metabolic dysfunction–associated steatotic liver disease;Hepatology;2024-08-07

3. Acute-on-chronic liver failure in metabolic dysfunction-associated fatty liver disease patients: a disease multiplier;Hepatology International;2024-08-06

4. One‐step non‐invasive diagnosis of metabolic dysfunction‐associated steatohepatitis and fibrosis in high‐risk population;United European Gastroenterology Journal;2024-08-04

5. Investigation of cardiovascular risk factors in diabetic and nondiabetic patients with nonalcoholic fatty liver disease;Journal of Research in Medical Sciences;2024-08